Biomarker: T014-IgE Cottonwood

Overview

T014-IgE Cottonwood measures immunoglobulin E (IgE) antibodies that specifically recognize cottonwood tree pollen, generally from Populus species. IgE is an antibody involved in immediate hypersensitivity reactions and can trigger mediator release from mast cells and basophils after allergen exposure. A detectable or elevated result indicates sensitization to cottonwood pollen, while a low or undetectable result indicates that cottonwood-specific IgE was not detected by the assay. The test supports evaluation of pollen-related allergic rhinitis, conjunctivitis, or asthma, but results must be interpreted with exposure history and symptoms because the concentration does not reliably predict clinical severity.

Clinical Use Cases

Supporting evaluation of suspected cottonwood-pollen allergy.
Assessing patients with seasonal allergic rhinitis, allergic conjunctivitis, or asthma when tree pollen is a suspected trigger.
Identifying sensitization when skin testing is unsuitable because of skin disease, medication use, age, or concern about systemic reactions.
Supporting selection of relevant environmental allergen-avoidance measures.
Contributing to an allergist’s overall assessment when considering allergen immunotherapy. Specific IgE results should not be used as the sole basis for diagnosis or treatment decisions.

Specimen Types

Serum from venous blood.
Serum from capillary blood, when validated by the laboratory.
Plasma may be accepted by some assay systems, but specimen requirements vary by laboratory.

Measurement Methods

Allergen-specific immunoassay using cottonwood pollen allergen bound to a solid phase.
Fluorescence enzyme immunoassay, such as an ImmunoCAP-type method.
Other validated specific-IgE immunoassays, including enzyme-linked or chemiluminescent formats, depending on the laboratory platform.
Results are commonly reported in kU/L or an equivalent standardized unit, with laboratory-specific interpretation categories.

Test Preparation and Influencing Factors

No fasting or other special preparation is generally required for an allergy blood test.
Patients should provide a complete medication list. Antihistamines generally do not affect blood testing in the same way they can affect skin testing, but medications should not be stopped unless directed by a healthcare professional.
Results should be interpreted with the patient’s symptoms, timing of symptoms, geographic and seasonal exposure, and other allergy-test results.
A positive result indicates sensitization and does not by itself prove that cottonwood pollen causes symptoms.
The amount of cottonwood-specific IgE does not reliably predict the severity of an allergic reaction.
Total IgE elevation, smoking, parasitic infection, and other conditions can complicate interpretation of allergy testing.
Serum should be separated appropriately and handled according to the testing laboratory’s requirements. Repeated freezing and thawing should be avoided.